GetTenderAI

France – Solutions médicamenteuses – Médicaments sous Autorisation d'Accès Compassionnel (AAC) et Autorisation d'Accès Précoce Pré-AMM (AP1) 2027

DeadlineSeptember 22, 2026 at 10:00 AM33 days left

AI summary

This tender concerns the supply of pharmaceutical solutions under Compassionate Access Authorization (AAC) and Pre-Market Early Access Authorization (AP1) for 2027. The contract covers medicines not yet fully approved, with an estimated value of €6 million over the contract duration. A purchasing group framework agreement will be executed through purchase orders, with separate attribution per lot.

#pharmaceuticals#compassionate access#pre-approval medicines#france#healthcare#medical supplies#framework agreement
Fit for

Pharmaceutical companies, authorized distributors, or wholesalers holding appropriate licenses for compassionate access and pre-market early access medicine distribution in France should bid.

Key requirements

Suppliers must be pharmaceutical distributors or manufacturers authorized to supply medicines under AAC and AP1 regulations in France. They must demonstrate capability to manage controlled distribution of pre-approval and compassionate-use medications and comply with healthcare procurement standards.

Frequently asked questions

  • What is this tender about?

    This tender concerns the supply of pharmaceutical solutions under Compassionate Access Authorization (AAC) and Pre-Market Early Access Authorization (AP1) for 2027. The contract covers medicines not yet fully approved, with an estimated value of €6 million over the contract duration. A purchasing group framework agreement will be executed through purchase orders, with separate attribution per lot.

  • What are the requirements for suppliers?

    Suppliers must be pharmaceutical distributors or manufacturers authorized to supply medicines under AAC and AP1 regulations in France. They must demonstrate capability to manage controlled distribution of pre-approval and compassionate-use medications and comply with healthcare procurement standards.

  • What type of company should bid?

    Pharmaceutical companies, authorized distributors, or wholesalers holding appropriate licenses for compassionate access and pre-market early access medicine distribution in France should bid.

  • Who is the buyer?

    The buyer is CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMOR.

  • When does this tender close?

    Submissions close on September 22, 2026.

  • What is the estimated value?

    The estimated value is 6,000,000 EUR.

Montant HT estimé pour la durée totale du contrat : 6000000.0 Euro(s) H.T. Les seuils sont exprimés en quantité au sein des documents de la consultation. Consultation lancée par un groupement de commandes. L'accord-cadre sera exécuté par l'émission de bons de commande. Chaque lot fera l'objet d'une attribution séparée. Les prestations sont réglées par des prix unitaires. Médicaments sous Autorisation d'Accès Compassionnel (AAC) et Autorisation d'Accès Précoce Pré-AMM (AP1) 2027

Buyer
CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMOR
Buyer ID: 57261·Madame la Directrice
10, rue Marcel Proust, 22027, Saint-Brieuc
0296017288correspondre@aws-france.comhttps://www.ch-stbrieuc.fr/
Body responsible for review procedures
Tribunal administratif de Rennes
Buyer ID: CFC9E4DB-D656-9F9F-08D8BD36BDD7A1A7
3, Contour de la Motte, 35044, Rennes
0223212828greffe.ta-rennes@juradm.fr
Other organization
Avenue-Web Systèmes
Buyer ID: CFC9E495-C97E-F9DC-1B23C8F973CDF596
38170, Seyssinet-Pariset
+33480041260publications-joue@aws-france.com

Computing match…

AI document analysis

We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.

Loading…